Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab PK with Chemotherapy in Head and Neck Cancer
NCT00756444Phase 2Completed
- Sponsor
- Amgen
- Start
- Oct 2008
- Primary completion
- Mar 2012
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of panitumumab in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Amgen. Started Oct 2008; status: completed.
02
Drugs
panitumumab
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00756444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00756444.